Twenty years of experience using Pelodex has proven its high effectiveness in the treatment of diseases of the nervous system diseases:

Nervous system diseases

• Diseases of the trigeminal nerve (trigeminal neuralgia with rare attacks);
• Diseases of the facial nerve (neuritis and neuropathies of an infectious and ischemic nature of the facial nerve in the early and late recovery period, including contractures);
• Diseases of nerve roots and plexuses (after two months or more, after the end of the acute period);
• Diseases of the nerves of the upper extremities (damages of the median nerve, ulnar nerve, tunnel syndromes, and lower extremities in the subacute stage of exacerbation that has been prolonged, in the early recovery period after one month after the disease. In the early remission stage, in the early and late recovery period);
• Diseases of intervertebral discs. Displacement of the intervertebral disc in the cervical department without myelopathy, posterior cervical sympathetic syndrome due to osteochondrosis of the cervical spine, in the subacute period with rare secondary hypothalamic crises);
• Degeneration of intervertebral discs in the cervical region, in the transverse region with moderate and mild pain;
• Injuries of nerve roots and plexuses, spinal nerves, peripheral nerves of the shoulder girdle and upper limbs, lower limbs, consequences of injuries to roots, plexuses, nerve columns that do not require surgical intervention, as well as after operations that are accompanied by motor and sensory disorders, signs of long-term recovery functions that are accompanied by motor and sensory disturbances, post-traumatic syndromes with sharply expressed causalgia, vascular and trophic disturbances and phantom pains;
• Inflammatory and trophic neuropathy, infectious polyneuritis — Guillain-Barré syndrome, polyneuropathy in intoxication, toxic infections. With a deficiency of vitamins of the B complex, with an allergy caused by medicinal products;
• Diseases of the autonomic nervous system, autonomic polyneuropathies, solaritis, sympathogantionitis, as well as segmental autonomic syndromes, including those of an occupational nature;
• Encephalitis, myolitis, encephalomyelitis, residual phenomena after tick-borne, post-influenza, vaccination, rheumatic and other forms of encephalitis, including hypothalamic, vegetative-vascular syndromes;
• Remote consequences of poliomyelitis, consequences of previous poliomyelitis, as well as after orthopedic operations (arthrosis, muscle transplantation) with signs of long-term recovery of functions);
• Spinal fractures with spinal cord injury (consequences of a spinal fracture with brain damage or concussion, hematomyelia, damage to the horse’s tail, with mild tetra and paraparesis after 4 months after trauma or neurosurgery);
• Consequences of penetrating craniocerebral injuries (with motor disorders in the form of central paresis. Traumatic encephalopathy during the recovery period);
• Diseases of the central nervous system in children (infantile cerebral palsy (with the phenomena of vegeto-vascular dystonia, cerebral insufficiency syndrome, hyperkinetic form with a predominance of choretic and dystonic hyperkinesis);
• Professional neuroses;
• Neurasthenias, Raynaud’s disease.